Lawrence M. Alleva
Director · Galera Therapeutics, Inc.
Individual
- 2024
- Aug 5, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lawrence M. Alleva files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mel Sorensen - $1K in GRTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lawrence M. Alleva?
Lawrence M. Alleva is a corporate insider, tracked as Director of Galera Therapeutics, Inc. (GRTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lawrence M. Alleva submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
